Healthway Medical Corporation Limited reported unaudited group earnings results for the second quarter and six months ended June 30, 2017. For the quarter, the company reported revenue of SGD 25,461,000 against SGD 23,188,000 a year ago. Loss before income tax was SGD 2,470,000 against SGD 64,000 a year ago. Loss attributable to shareholders was SGD 2,624,000 or 0.09 cents per basic and diluted share against profit of SGD 55,000 or nil per share a year ago. Net cash used in operating activities was SGD 8,121,000 against net cash generated from operating activities of SGD 1,753,000 a year ago. Addition to property, plant and equipment was SGD 601,000 against SGD 202,000 a year ago. For the six months, the company reported revenue of SGD 48,625,000 against SGD 47,888,000 a year ago. Loss before income tax was SGD 2,716,000 against profit of SGD 626,000 a year ago. Loss attributable to shareholders was SGD 3,128,000 or 0.11 cents per basic and diluted share against profit of SGD 635,000 or 0.03 cents per basic and diluted share a year ago. Net cash used in operating activities was SGD 12,301,000 against net cash generated from operating activities of SGD 5,326,000 a year ago. Addition to property, plant and equipment was SGD 889,000 against SGD 245,000 last year.